Literature DB >> 1595040

Giant basal prolactinoma extending into the nasal cavity.

Y Iwai1, A Hakuba, V K Khosla, M Nishikawa, J Katsuyama, Y Inoue, S Nishimura.   

Abstract

An unusual case of a giant prolactinoma extending to the nasopharynx and nasal cavity is presented. A 35-year-old man admitted for nasal obstruction and visual disturbances was found to have bilateral anosmia, right homonymous hemianopsia, and a right hemiparesis. The serum prolactin level was 13,300 ng/mL. Radiological examination revealed a large mass invading the skull base and extending into the suprasellar region and the left frontal lobe superiorly and into the nasopharynx inferiorly. Subtotal removal was done through a bilateral orbitofrontal craniotomy, which was followed by radiotherapy and bromocriptine administration. Immunohistochemical analysis confirmed a prolactinoma. The rarity of such a tumor, its location and extension, and the usefulness of magnetic resonance imaging and immunohistochemistry are stressed. Pertinent literature is reviewed.

Entities:  

Mesh:

Year:  1992        PMID: 1595040     DOI: 10.1016/0090-3019(92)90153-e

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

Review 1.  A giant prolactinoma presenting with unilateral exophthalmos: effect of cabergoline and review of the literature.

Authors:  J Berwaerts; J Verhelst; R Abs; B Appel; C Mahler
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

2.  Clinical presentation and response to therapy in patients with massive prolactin hypersecretion.

Authors:  Susana Mascarell; David H Sarne
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

3.  Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist.

Authors:  Moon Sool Yang; Jae Won Hong; Seung Koo Lee; Eun Jig Lee; Sun Ho Kim
Journal:  J Neurooncol       Date:  2010-11-24       Impact factor: 4.130

4.  Macroprolactinomas presenting as nasal polyps: a series of three cases.

Authors:  P C Johnston; H C Courtney; S J Hunter; D R Mc Cance
Journal:  Ir J Med Sci       Date:  2009-03-14       Impact factor: 1.568

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.